NCT03467789 2024-10-17
Vitamin D as a Nutritional Neoadjuvant During Photodynamic Therapy of Basal Cell Carcinoma
Case Comprehensive Cancer Center
Phase 1 Completed
Clinical Trials
11 trialsNCT00957229 2021-01-11
GDC-0449
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT01556009 2020-11-02
Vismodegib
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT00489086 2020-10-29
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT02157623 2020-07-30
Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
The Cleveland Clinic
Phase NA Completed
NCT03767439 2019-12-18
Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome
Columbia University
Phase 2 Withdrawn
NCT02303041 2019-01-29
Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
Stanford University
Phase 2 Terminated
NCT01893892 2017-08-04
Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms
Stanford University
Phase NA Completed
NCT02100371 2017-07-11
Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
University Health Network, Toronto
Phase NA Completed
NCT00433485 2016-09-23
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Yale University
Phase 1 Completed
NCT00783965 2016-02-11
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed